Skip to main content
Fig. 5 | Acta Neuropathologica Communications

Fig. 5

From: C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers

Fig. 5

C9orf72 reduction and C9orf72-AS increase in FTD brains. Quantitative comparisons of C9orf72 expression in frontal cortex of controls and FTD brains: reduction in the expression of C9orf72 total (a) and transcript 1 (b) is shown in C9orf72-HRE, FTD-GRN and FTD-MAPT mutation carriers. c Increase of C9orf72-AS3 in all FTD cases as compared to controls. Expression values are expressed as NRQs values, measurements are performed in triplicates and error bars reflect standard deviations

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us